Project Delta

Cyted is a digital diagnostic company focused on the early detection of gastrointestinal diseases, particularly esophageal cancer. The company is the commercial lead for Project DELTA (integrateD diagnostic solution for EarLy deTection of oesophageal cAncer), a major UK-based initiative funded by Innovate UK and Cancer Research UK. Cyted's core offering is the Cytosponge-TFF3 test, a non-endoscopic 'pill-on-a-string' device that collects esophageal cells for analysis using proprietary AI algorithms and molecular biomarkers. By providing a simple, office-based alternative to traditional endoscopy, Cyted aims to streamline diagnostic workflows and improve survival rates through earlier intervention in at-risk populations.